Compare Solaredge Technologies Inc (SEDG) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Solaredge Technologies Inc vs Zimmer Biomet Holdings Inc — how do they compare? Solaredge Technologies Inc trades at $50.26 (market cap $2.96B), while Zimmer Biomet Holdings Inc trades at $90.03 (market cap $17.36B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 5.9× Solaredge Technologies Inc's market cap, and Zimmer Biomet Holdings Inc pays a 1.07% dividend while Solaredge Technologies Inc pays none. Which is the better fit depends on your goals.
| SEDG | ZBH | |
|---|---|---|
Market Cap | $2.96B | $17.36B |
Sector | Technology | Health |
52-Week High | $78.51 | $107.71 |
52-Week Low | $24.42 | $79.58 |
Enterprise Value | $2.89B | $24.40B |
Dividend Yield | — | 1.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SolarEdge Technologies (SEDG) trades at $50.27, down 5.98% in the last session, reflecting ongoing volatility in the solar sector. The stock shows bearish technical signals with negative moving averages, though RSI suggests potential oversold conditions. Fundamentally, the company faces challenges with a net income margin of -28.56% and negative ROE of -72.5%, despite recent revenue stabilization at $1.18 billion for 2025. Recent news highlights sector-wide volatility and upcoming Q2 2026 earnings on August 5, 2026, which will be critical for investor confidence.
The outlook remains cautious with significant execution risks and competitive pressures in the solar market. While analyst consensus shows a mixed view with 20.83% buy ratings and a $41.27 price target below current levels, the stock's proximity to key support at $47 suggests potential for near-term stability if earnings beat expectations. However, persistent negative profitability and high debt levels pose substantial risks to shareholder value.
Zimmer Biomet (ZBH) trades at $88.92, down 2.41% on the day, with a bearish technical signal but strong fundamentals including a 70.03% gross margin and three consecutive quarterly EPS beats. Revenue grew to $8.23B in 2025, though net income margin compressed to 8.56%. The company announced a $1 billion share repurchase increase and expansion in India, while maintaining a dividend.
The stock offers a 10% upside to the $97.67 consensus price target, supported by value metrics and operational strength, but faces risks from rising debt levels and competitive pressures. Analyst sentiment is mixed with 40% buy ratings, suggesting cautious optimism amid near-term technical weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Solaredge Technologies Inc
SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers. Additionally, the company has nonsolar products targeting energy storage and e-mobility.
Read more on SEDG →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
